Dr Charles Tannock

Member of the European Parliament for London

EC and Israel -Conformity Assessment and Acceptance of Industrial Products

Delivered in Plenary - 23rd October 2012

Mr President

The ACAA Protocol is not about human rights, the occupied territories or Israel’s approach to the Middle East peace process. It is about trade and unblocking technical barriers which currently exist between producers and consumers: one of the fundamental objectives of the European Union

For the record, and for those who have raised the issue repeatedly, I have received repeated assurances that there are no pharmaceutical products being manufactured in the settlements. Supporting ACAA does not endorse the expansion of settlements or indeed any other Israeli policy, neither does it increase goods with a provenance from the occupied territories. It does, however, enable Israel, which has a highly sophisticated regulatory authority, to certify medical products, a task for which it is more than equipped, to the benefit of all of Europe’s citizens.

People here, who have sought to block it, are cutting off their nose to spite their face. Israel is a global leader in producing cheap and safe, effective generic medicines. Those opposed to ACAA are more interested in bashing Israel than in promoting the welfare of Europe’s sick.